Viruses 2012, 4(10), 2031-2048; doi:10.3390/v4102031
Review

Pathogenesis of Lassa Fever

email and * email
Received: 3 September 2012; in revised form: 28 September 2012 / Accepted: 3 October 2012 / Published: 9 October 2012
(This article belongs to the Special Issue Arenaviruses)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Lassa virus, an Old World arenavirus (family Arenaviridae), is the etiological agent of Lassa fever, a severe human disease that is reported in more than 100,000 patients annually in the endemic regions of West Africa with mortality rates for hospitalized patients varying between 5-10%. Currently, there are no approved vaccines against Lassa fever for use in humans. Here, we review the published literature on the life cycle of Lassa virus with the specific focus put on Lassa fever pathogenesis in humans and relevant animal models. Advancing knowledge significantly improves our understanding of Lassa virus biology, as well as of the mechanisms that allow the virus to evade the host’s immune system. However, further investigations are required in order to design improved diagnostic tools, an effective vaccine, and therapeutic agents.
Keywords: arenavirus; Lassa virus; pathogenesis; cell-mediated immunity
PDF Full-text Download PDF Full-Text [319 KB, uploaded 9 October 2012 13:53 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Yun, N.E.; Walker, D.H. Pathogenesis of Lassa Fever. Viruses 2012, 4, 2031-2048.

AMA Style

Yun NE, Walker DH. Pathogenesis of Lassa Fever. Viruses. 2012; 4(10):2031-2048.

Chicago/Turabian Style

Yun, Nadezhda E.; Walker, David H. 2012. "Pathogenesis of Lassa Fever." Viruses 4, no. 10: 2031-2048.


Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert